Schonfeld Strategic Advisors LLC Aytu Biopharma, Inc Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.08 $7,774 - $18,252	-16,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $108 - $155	-100 Reduced 0.59%	16,900 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $4,320 - $9,440	-3,200 Reduced 15.84%	17,000 $23,000
Q3 2021 Nov 16, 2021	SELL	$2.78 - $5.12 $16,568 - $30,515	-5,960 Reduced 22.78%	20,200 $58,000
Q2 2021 Aug 16, 2021	SELL	$4.73 - $7.56 $4,446 - $7,106	-940 Reduced 3.47%	26,160 $131,000
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $168,833 - $267,748	27,100 New	27,100 $206,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $101M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.